In line with our expectations, 2022FY marked a continuation of the revenue expansion theme sustained since 2020FY. On the back of expansion in distribution channels, increased sales volume and price increment across Over-the-Counter (OTC) products, Fidson Healthcare Plc. (FIDSON) recorded a significant double-digit top-line uptick for the third consecutive year.
